The Nanotoxicology section welcomes research encompassing both theoretical and experimental approaches, with the aim to clarify the potential hazards of nanomaterials to human health and the environment, and their mitigation. We wish to promote a diversity of views and contributions coming from a broad range of disciplines spanning material sciences, (eco)toxicology, exposure assessment, risk assessment, but also epidemiology, regulatory sciences, and theoretical disciplines, including in silico modeling.Read More
Our mission is to create a global, open access forum for scientists engaged in the interdisciplinary field of nanotoxicology. Our aim is to promote scientific excellence in the field.
Nanotoxicology is coming of age. The term was coined 15 years ago to describe a new frontier in particle toxicology relevant to both human health and the environment. Since then, nanotoxicology has developed into an interdisciplinary research field in its own right covering all aspects of incidental or intentionally produced nanomaterials, from material characterization to hazard assessment and exposure assessment, and risk assessment as well as risk management. The research field encompasses both theoretical and experimental approaches, with the aim to clarify the potential hazards of nanomaterials to human health and the environment, and their mitigation. Nanotoxicology (sometimes referred to as nanosafety research) is an integral component of the nanotechnological revolution. The overarching objective is to ensure the safe and sustainable use of nanomaterials and nano-enabled products. Nanotoxicology may also provide new insights into biological mechanisms by elucidating the interactions of engineered nanomaterials with biological nano-machineries at the cellular or subcellular level. Nanotoxicology is a relatively new discipline that embraces new developments in toxicology including the application of systems biology and theoretical modeling approaches. Currently lacking are epidemiological studies of nanomaterial effects on the human population and we encourage such efforts to complement other toxicological studies.
To promote the development of nanotoxicology, we encourage contributions that may serve to:
We wish to promote a diversity of views and contributions coming from a broad range of disciplines spanning material sciences, (eco)toxicology, exposure assessment, risk assessment, but also epidemiology, regulatory sciences, and theoretical disciplines, including in silico modeling. We encourage contributions on the application of nanomaterials, e.g., in medicine, provided that they shed light on the toxicity (or biocompatibility) of materials used in such applications. Toxicological studies should always endeavor to present characterization of the tested nanomaterials that is fit-for-purpose, to support the interpretation of the toxicological data.
Indexed in: Google Scholar, CrossRef
Nanotoxicology welcomes submissions of the following article types: Brief Research Report, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review and Specialty Grand Challenge.
All manuscripts must be submitted directly to the section Nanotoxicology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Nanotoxicology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Toxicology.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org